VanEckHealthPPH · Nasdaq
VanEck Pharmaceutical ETF (PPH)
- Price
- $109.44
- —11 Sept 2026
- Assets
- $1B
- Total net assets
- Expense ratio
- 0.36%
- Category 1.00%
- Yield
- 1.92%
- Trailing distributions
- 3Y CAGR
- 12.3%-1.2%
- Category 13.5%
- 5Y CAGR
- 10.3%+8.4%
- Category 1.9%
Loading NAV history…
VanEck Pharmaceutical ETF
Calendar-year returns
Fund only: no comparison series covers this fund's history.
Risk statistics
Five years of daily closes. Risk-free rate 4% a year.
- Standard deviation
- —
- Maximum drawdown
- —
- Sharpe ratio
- —
- Sortino ratio
- —
- Beta
- —
- Alpha
- —
- R²
- —
- Information ratio
- —
- Upside capture
- —
- Downside capture
- —
- Tracking error
- —
Holdings
The 10 largest positions make up 72.8% of the fund.
Top holdings
| Ticker | Holding | Weight |
|---|---|---|
| LLY | Eli Lilly and Co | 19.11% |
| MRK | Merck & Co Inc | 10.96% |
| NVS | Novartis AG ADR | 10.06% |
| PFE | Pfizer Inc | 5.05% |
| BMY | Bristol-Myers Squibb Co | 4.98% |
| NVO | Novo Nordisk AS ADR | 4.92% |
| MCK | McKesson Corp | 4.70% |
| ABBV | AbbVie Inc | 4.48% |
| JNJ | Johnson & Johnson | 4.43% |
| GSK | GSK PLC ADR | 4.13% |
Portfolio valuation
Weighted averages of what the fund holds.
- P/E
- 24.7
- P/B
- 4.4
- P/S
- 1.6
- P/CF
- 15.7
Sector allocation
Share of the equity the fund holds.
- Health care100.0%
Asset mix
- Stocks100.0%
ETF details
- Issuer
- VanEck
- Category
- Equity · Health
- Ticker
- PPH
- Exchange
- Nasdaq
- Inception
- 20 Dec 2011 (14.7 years)
- Structure
- Exchange Traded Fund
- Expense ratio
- 0.36% (category 1.00%)
- Holdings turnover
- 30% (category 51%)
- Distribution yield
- 1.92%
- Beta, 3 years
- 0.43
- Total net assets
- $1B
Prices and returns as of 11 Sept 2026; total return with distributions reinvested, before brokerage and taxes. Not investment advice.
Other health ETFs
Other ETFs in the Health category.
- PBPH · Portfolio Building Block World Pharma and Biotech Index ETFPortfolio Building Block ETFs · $1B · ER 0.13%
- RSPH · Invesco S&P 500 Equal Weight Health Care ETFInvesco · $832.8M · ER 0.40%5Y 3.5%
- XPH · State Street SPDR S&P Pharmaceuticals ETFState Street Investment Management · $586.9M · ER 0.35%5Y 8.4%
- PJP · Invesco Pharmaceuticals ETFInvesco · $532.5M · ER 0.58%5Y 10.4%
- PBE · Invesco Biotechnology & Genome ETFInvesco · $470.6M · ER 0.59%5Y 4.3%
- BBH · VanEck Biotech ETFVanEck · $469.4M · ER 0.35%5Y 1.6%